Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Viveve Medical (NQ: VIVE)
2.150 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EST, Nov 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 77,400
Open 2.140
Bid (Size) 2.000 (2)
Ask (Size) 2.570 (30)
Prev. Close 2.150
Today's Range 2.110 - 2.200
52wk Range 1.600 - 5.400
Shares Outstanding 31,269,388
Dividend Yield N/A
Performance
YTD
-58.57%
-58.57%
1 Month
-38.57%
-38.57%
3 Month
-30.87%
-30.87%
6 Month
+16.22%
+16.22%
1 Year
-57.17%
-57.17%
Top News
More News
Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte
Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that the company has been included in Deloitte’s 2018 Technology Fast 500, a list... Read More
from GlobeNewswire News Releases
Viveve to Present at Stifel 2018 Healthcare Conference
Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and director, will present at the Stifel... Read More
from GlobeNewswire News Releases
More News
Read More
Viveve Reports Third Quarter 2018 Financial Results
from GlobeNewswire News Releases
Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
from GlobeNewswire News Releases
Viveve to Present at Ladenburg Thalmann 2018 Healthcare Conference
from GlobeNewswire News Releases
Viveve Appoints Two New Independent Board Members
from GlobeNewswire News Releases
Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence
from GlobeNewswire News Releases
Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference
from GlobeNewswire News Releases
Viveve Initiates LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
from GlobeNewswire News Releases
Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X